服务热线
15339069646服务热线
15339069646| Item | Name | Cat. No. | Tag/Conjugates |
| Anti-CD3D&CD3E;CD19 mAbs [Surovatamig Biosimilar] (MABL-5263) | MABL-5263 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;na |
| Anti-HAVCR2/TIM3 mAbs [Surzebiclimab Biosimilar] (MABL-5264) | MABL-5264 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-F7a/F7A/FVIIa/FVIIA;TREML1/GLTL1825/PRO3438/TLT-1/TLT1 mAbs [Sutacimig Biosimilar] (MABL-5265) | MABL-5265 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;Kappa |
| Anti-C1S mAbs [Sutimlimab Biosimilar] (MABL-5266) | MABL-5266 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-VEGFA mAbs [Suvemcitug Biosimilar] (MABL-5267) | MABL-5267 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-HIV-1 gp120 mAbs [Suvizumab Biosimilar] (MABL-5268) | MABL-5268 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD24 mAbs [Suvonstobart Biosimilar] (MABL-5269) | MABL-5269 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Staphylococcus aureus Toxin A mAbs [Suvratoxumab Biosimilar] (MABL-5270) | MABL-5270 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFSF13B/CD257/BAFF mAbs [Tabalumab Biosimilar] (MABL-5271) | MABL-5271 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL6 mAbs [Tabirafusp Biosimilar] (MABL-5272) | MABL-5272 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-FZD10/CD350 mAbs [Tabituximab Biosimilar] (MABL-5273) | MABL-5273 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Alpha Ferroprotein mAbs [Tacatuzumab Biosimilar] (MABL-5274) | MABL-5274 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ITGA2B and ITGB3 mAbs [Tadocizumab Biosimilar] (MABL-5275) | MABL-5275 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD19 mAbs [Tafasitamab Biosimilar] (MABL-5276) | MABL-5276 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PCSK9 mAbs [Tafolecimab Biosimilar] (MABL-5277) | MABL-5277 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-MUC16/CA125 mAbs [Sofituzumab Biosimilar] (MABL-5239) | MABL-5239 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDL1/CD274 mAbs [Solabafusp Biosimilar] (MABL-5240) | MABL-5240 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-APP mAbs [Solanezumab Biosimilar] (MABL-5241) | MABL-5241 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-EPCAM/CD326;CD3E mAbs [Solitomab Biosimilar] (MABL-5242) | MABL-5242 | ELISA, FACS, Functional assay, in vivo binding | na;na, Kappa;Kappa |
| Anti-VSIR/VISTA/B7H5/PD1H/SISP1 mAbs [Solnerstotug Biosimilar] (MABL-5243) | MABL-5243 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn